Zacks Investment Management Eli Lilly & CO Transaction History

Zacks Investment Management

  • $11.4 Billion
  • Q3 2024

A detailed history of Zacks Investment Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Zacks Investment Management holds 113,955 shares of LLY stock, worth $90.7 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
113,955
Previous 103,744 9.84%
Holding current value
$90.7 Million
Previous $93.9 Million 7.48%
% of portfolio
0.88%
Previous 1.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$772.14 - $960.02 $7.88 Million - $9.8 Million
10,211 Added 9.84%
113,955 $101 Million
Q2 2024

Aug 14, 2024
BUY
$724.87 - $909.04 $5.5 Million - $6.9 Million
7,586 Added 7.89%
103,744 $93.9 Million
Q1 2024

May 15, 2024
BUY
$592.2 - $792.28 $5.19 Million - $6.94 Million
8,762 Added 10.03%
96,158 $74.8 Million
Q4 2023

Feb 14, 2024
SELL
$525.19 - $619.13 $776,230 - $915,074
-1,478 Reduced 1.66%
87,396 $50.9 Million
Q3 2023

Nov 14, 2023
BUY
$434.7 - $599.3 $687,260 - $947,493
1,581 Added 1.81%
88,874 $47.7 Million
Q2 2023

Aug 15, 2023
BUY
$350.74 - $468.98 $3.59 Million - $4.8 Million
10,243 Added 13.29%
87,293 $40.9 Million
Q2 2023

Aug 14, 2023
BUY
$350.74 - $468.98 $8.5 Million - $11.4 Million
24,248 Added 45.92%
77,050 $36.1 Million
Q1 2023

May 15, 2023
SELL
$310.63 - $364.82 $12.8 Million - $15.1 Million
-41,268 Reduced 43.87%
52,802 $18.1 Million
Q4 2022

Feb 14, 2023
BUY
$321.55 - $374.67 $1.14 Million - $1.33 Million
3,550 Added 3.92%
94,070 $34.4 Million
Q3 2022

Nov 14, 2022
BUY
$296.48 - $337.87 $582,286 - $663,576
1,964 Added 2.22%
90,520 $29.3 Million
Q2 2022

Aug 15, 2022
BUY
$278.73 - $327.27 $6.11 Million - $7.18 Million
21,930 Added 32.92%
88,556 $28.7 Million
Q1 2022

May 13, 2022
BUY
$234.69 - $291.66 $1.73 Million - $2.15 Million
7,377 Added 12.45%
66,626 $19.1 Million
Q4 2021

Feb 15, 2022
BUY
$224.85 - $279.04 $4.26 Million - $5.29 Million
18,957 Added 47.05%
59,249 $16.4 Million
Q3 2021

Nov 15, 2021
BUY
$221.6 - $272.71 $8.53 Million - $10.5 Million
38,503 Added 2152.21%
40,292 $9.31 Million
Q2 2021

Aug 16, 2021
BUY
$180.55 - $233.54 $7,041 - $9,108
39 Added 2.23%
1,789 $411,000
Q1 2021

May 17, 2021
BUY
$164.32 - $212.72 $3,779 - $4,892
23 Added 1.33%
1,750 $327,000
Q4 2020

Feb 16, 2021
SELL
$130.46 - $172.63 $3.62 Million - $4.79 Million
-27,734 Reduced 94.14%
1,727 $292,000
Q3 2020

Nov 16, 2020
SELL
$146.22 - $169.13 $6.18 Million - $7.15 Million
-42,293 Reduced 58.94%
29,461 $4.36 Million
Q2 2020

Aug 14, 2020
SELL
$136.42 - $164.18 $2.78 Million - $3.34 Million
-20,372 Reduced 22.11%
71,754 $11.8 Million
Q1 2020

May 15, 2020
SELL
$119.05 - $147.35 $68,096 - $84,284
-572 Reduced 0.62%
92,126 $12.8 Million
Q4 2019

Feb 14, 2020
BUY
$106.92 - $132.43 $275,853 - $341,669
2,580 Added 2.86%
92,698 $12.2 Million
Q3 2019

Nov 14, 2019
BUY
$106.79 - $116.16 $286,837 - $312,005
2,686 Added 3.07%
90,118 $10.1 Million
Q2 2019

Aug 14, 2019
BUY
$110.79 - $129.32 $286,946 - $334,938
2,590 Added 3.05%
87,432 $9.69 Million
Q1 2019

May 15, 2019
SELL
$111.31 - $131.02 $25.9 Million - $30.5 Million
-232,994 Reduced 73.31%
84,842 $11 Million
Q4 2018

Feb 14, 2019
SELL
$105.9 - $118.64 $53,373 - $59,794
-504 Reduced 0.16%
317,836 $36.8 Million
Q3 2018

Nov 14, 2018
BUY
$85.86 - $107.31 $6.61 Million - $8.27 Million
77,039 Added 31.93%
318,340 $34.2 Million
Q2 2018

Aug 14, 2018
BUY
$75.7 - $86.88 $176,759 - $202,864
2,335 Added 0.98%
241,301 $20.6 Million
Q1 2018

May 14, 2018
BUY
$74.21 - $87.6 $244,002 - $288,028
3,288 Added 1.4%
238,966 $18.5 Million
Q4 2017

Feb 14, 2018
BUY
$81.94 - $87.89 $356,357 - $382,233
4,349 Added 1.88%
235,678 $19.9 Million
Q3 2017

Nov 14, 2017
BUY
$77.07 - $85.54 $17.8 Million - $19.8 Million
231,329
231,329 $19.8 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Zacks Investment Management Portfolio

Follow Zacks Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email